Sign in

CIK 0001709941 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

BioAge Labs, Inc.

Sign in to watch
Ticker
BIOA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
474721157
Phone
510-806-1445
Business address
5885 HOLLIS STREET, SUITE 370, EMERYVILLE, CA, 94608
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations
  3. ARS Other Annual Report to Security Holders
  4. DEFA14A Proxy Proxy Materials
  5. DEF 14A Proxy Proxy Statement
  6. S-8 Other Securities Offered to Employees in Benefit Plans
  7. 10-K Report Annual Report
  8. 8-K Event Results of operations
  9. 4/A Open-market buy Director bought 3,000 shares at $18.00 ($54,000)
  10. 4 Open-market buy Principal Accounting Officer bought 2,632 shares at $18.00 ($47,376)
  11. 4/A Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  18. SCHEDULE 13G Stake Statement of Beneficial Ownership
  19. 4 Derivatives Options or other derivatives
  20. SC 13G Stake Amended Statement of Ownership

Page 5 of 8 · 157 filings